What is Bone Graft Substitutes?
Bone graft substitutes are defined as the synthetic bone substitute material which is used to fill bone defects and promote bone healing. It helps to improve the success of the autogenous bone graft. There are a various function of bone graft such as structural support of articular fracture, void filler to prevent fracture, improved healing of fracture & nonunions, among others. Demand for Bone graft substitutes has increased due to an increase in inpatient surgeries. For instance, according to Disease Control and Prevention, in 2014, more than 51.4 million inpatients surgeries were performed in the United States. Out of these, more than 719,000 were knee replacements and 332,000 hip replacements. Hence, the rising number of knee & hip replacements surgeries are projected to drive the global bone graft substitutes market over the forecast period.
The market study is broken down, by Application (Spinal Fusion, Dental, Joint Reconstruction, Craniomaxillofacial, Foot and Ankle and Long Bone) and major geographies with country level break-up.
The bone graft substitutes market is highly fragmented with the presence of various players operating in the market. There are various players operating in the market such as Stryker Corporation (United States), NuVasive, Inc. (United States), DePuy Synthes (United States), among others. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Stryker Corporation (united States), NuVasive, Inc. (United States), DePuy Synthes (United States), Wright Medical Group N.V. (Netherland), Orthofix Holdings, Inc. (United States), Medtronic, PLC (Ireland), Integra LifeSciences Corp (United States), Baxter Healthcare Corporation (United States), Zimmer Biomet Holdings, Inc. (United States) and AlloSource (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Smith & Nephew Plc (UK), RTI Surgical, Inc. (USA), NovaBone Products LLC ((United States), SeaSpine Holdings Corporation (United States) and Exactech, Inc. (United States).
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Bone Graft Substitutes market by Type, Application and Region.
On the basis of geography, the market of Bone Graft Substitutes has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Material Type, the sub-segment i.e. Natural {Autografts will boost the Bone Graft Substitutes market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Users , the sub-segment i.e. Hospitals will boost the Bone Graft Substitutes market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In March 2019, the Medtronic, PLC (Ireland) company has launched Grafton demineralized bone matrix bone grafting product in Japan. It is widely used for spinal and orthopedic procedures. Hence, this launched will benefit increase in the product portfolio of the company.
Market Trend
- Rapid Advancements Witnessed in the Technology as well as Product Developments
Market Drivers
- Rising Number of Musculoskeletal Conditions across the World
- Growing Medical Tourism offering Advanced Healthcare Services
Opportunities
- Rising Demand from Emerging Economics such as India, China and others
Restraints
- Issue related to Limited supply as well as Donor Site Morbidity
Challenges
- Low Adoption of Bone Graft Substitute in some region such as Africa
Key Target Audience
Bone Graft Substitutes Manufacturers Companies, Regulatory Bodies, Intermediary Suppliers and End Users
Key Finding and Research Objectives
The primary objective is to underline the competitive structure of bone graft substitutes Industry. The research includes study of several small to medium-sized companies that compete with each other and large enterprises. Identify regional factors impacting production studied at Global scale. Insights on Regulatory & Economic policies by geography giving ease to Market entry. What product features & benefits offered by Industry players studied and broken down by diverse group of customer class.
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.